title: Intact HCG, free HCG beta subunit and HCG beta core fragment: longitudinal patterns in urine during early pregnancy.
abstract: BACKGROUND
  Detecting and monitoring early pregnancy depend on the measurement of HCG. Little is known about how production of various forms of HCG may evolve over the earliest weeks of pregnancy, particularly in naturally conceived pregnancies.
  
  
  METHODS
  We describe the daily excretion of three urinary HCG analytes during the first 6 weeks post-conception in 37 naturally conceived pregnancies ending in singleton birth. We assayed daily first morning urine samples for intact HCG, free beta subunit and beta?core fragment, plus the combined measurement of these HCG forms. We calculated doubling times for each analyte and the inter- and intra-subject day-to-day variation.
  
  
  RESULTS
  Intact HCG and the free beta subunit were initially the predominant forms of HCG, with the beta core fragment emerging as the predominant form in the fifth week after conception. Intact HCG and the free beta subunit showed the most day-to-day variability, and were transiently undetectable even 10 days after detection of pregnancy. The most stable estimate of doubling time was provided by the combined measurement of all these forms.
  
  
  CONCLUSIONS
  Although intact HCG is usually regarded as the main analyte for detection and monitoring of early pregnancy, it can fluctuate markedly during early pregnancy. This variability could affect pregnancy test results based on early pregnancy urine, and may distort estimates of doubling time. Assays that combine several forms of HCG may be more reliable.
authors.affiliation: Brooklyn College, The City University of New York, New York, NY, USA.
authors.forename: Ruth
authors.initials: R
authors.lastname: McChesney
authors.forename: Allen J
authors.initials: AJ
authors.lastname: Wilcox
authors.forename: John F
authors.initials: JF
authors.lastname: O'Connor
authors.forename: Clarice R
authors.initials: CR
authors.lastname: Weinberg
authors.forename: Donna D
authors.initials: DD
authors.lastname: Baird
authors.forename: John P
authors.initials: JP
authors.lastname: Schlatterer
authors.forename: D Robert
authors.initials: DR
authors.lastname: McConnaughey
authors.forename: Steven
authors.initials: S
authors.lastname: Birken
authors.forename: Robert E
authors.initials: RE
authors.lastname: Canfield
mesh_terms: D000328:Adult; D015415:Biomarkers; D006063:Chorionic Gonadotropin / Q000652:urine*; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000652:urine*; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D010060:Ovulation; D011247:Pregnancy; D011258:Pregnancy Tests / Q000379:methods* / Q000592:standards*; D011261:Pregnancy Trimester, First / Q000652:urine; D011446:Prospective Studies; D015203:Reproducibility of Results
chemical_list: D015415:Biomarkers; D006063:Chorionic Gonadotropin; D018997:Chorionic Gonadotropin, beta Subunit, Human